Seven Fleet Capital Management LP: 13F holdings
CIK 20920212026Q2
| Positions | 96 |
|---|
| Reported value | $605.9m |
|---|
| Filed | 2026-08-17 |
|---|
Change since last quarter
| Positions | 96 (-19 vs prior quarter) |
|---|
| Reported value | $605.9m (+90.4%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| CGON CG ONCOLOGY INC | 1,886,236 | $134.0m | 22.1% |
| TNGX TANGO THERAPEUTICS INC | 3,228,144 | $95.7m | 15.8% |
| RVMD REVOLUTION MEDICINES INC | 242,029 | $45.3m | 7.5% |
| PHARVARIS N V | 774,501 | $26.8m | 4.4% |
| LQDA LIQUIDIA CORPORATION | 256,603 | $20.5m | 3.4% |
| ELVN ENLIVEN THERAPEUTICS INC | 365,386 | $18.5m | 3.1% |
| ABVX ABIVAX SA | 111,334 | $14.8m | 2.4% |
| AVTX AVALO THERAPEUTICS INC | 770,765 | $14.2m | 2.4% |
| MIRM MIRUM PHARMACEUTICALS INC | 110,393 | $12.9m | 2.1% |
| ASSEMBLY BIOSCIENCES INC | 433,147 | $11.9m | 2.0% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="2092021")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples